ARTICLE | Clinical News
DCVAC/PCa: Phase III started
June 9, 2014 7:00 AM UTC
Sotio a.s., Prague, Czech Republic Product: DCVAC/PCa Business: Cancer Molecular target: NA Description: Active cellular immunotherapy for prostate cancer that uses a patient's dendritic cells to ind...